In the few reports that have examined the significance of DCX in the CSF from human pediatric patients, levels of DCX were suggested to reflect a neuroprotective response after traumatic brain injury, after nerve growth factor or methotrexate treatment [17–21]; Nevertheless, the number of patients was limited, and DCX was measured semi-quantitatively by western blot, without rigorous validation. This evidence concerns the gene DCX and brain injury.